Cargando…

Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts

Two centuries ago in 1817, James Parkinson provided the first medical description of Parkinson’s disease, later refined by Jean-Martin Charcot in the mid-to-late 19th century to include the atypical parkinsonian variants (also termed, Parkinson-plus syndromes). Today, Parkinson’s disease represents...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeed, Usman, Compagnone, Jordana, Aviv, Richard I., Strafella, Antonio P., Black, Sandra E., Lang, Anthony E., Masellis, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370489/ https://www.ncbi.nlm.nih.gov/pubmed/28360997 http://dx.doi.org/10.1186/s40035-017-0076-6

Ejemplares similares

Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes
por: Saeed, Usman, et al.
Publicado: (2020)

Effects of white matter hyperintensities, neuropsychiatric symptoms, and cognition on activities of daily living: Differences between Alzheimer's disease and dementia with Lewy bodies
por: Mirza, Saira Saeed, et al.
Publicado: (2022)

VMAT2 availability in Parkinson’s disease with probable REM sleep behaviour disorder
por: Valli, Mikaeel, et al.
Publicado: (2021)

Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
por: Mihaescu, Alexander S., et al.
Publicado: (2022)

Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
por: Potashkin, Judith A., et al.
Publicado: (2012)

Disorders of the Oral Cavity in Parkinson's Disease and Parkinsonian Syndromes
por: Zlotnik, Yair, et al.
Publicado: (2015)

Eye Movements in Parkinson’s Disease and Inherited Parkinsonian Syndromes
por: Pretegiani, Elena, et al.
Publicado: (2017)

Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story
por: Lam, Benjamin, et al.
Publicado: (2009)

DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease
por: Pereira, Joana B., et al.
Publicado: (2023)

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders
por: Constantinescu, Radu, et al.
Publicado: (2013)

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
por: van Eimeren, Thilo, et al.
Publicado: (2019)

Sleep disturbances in Parkinson’s disease are associated with central parkinsonian pain
por: Vila-Chã, N, et al.
Publicado: (2019)

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders
por: AKDEMİR, Ümit Özgür, et al.
Publicado: (2021)

Utility of susceptibility-weighted imaging in Parkinson’s disease and atypical Parkinsonian disorders
por: Wang, Zhibin, et al.
Publicado: (2016)

Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra
por: Ayton, Scott, et al.
Publicado: (2016)

High Prevalence of Early Parkinson's Disease in Patients With Subtle Parkinsonian Signs
por: Sasaki, Shoichi
Publicado: (2021)

Age‐Related Parkinsonian Signs in Microdeletion 22q11.2
por: Boot, Erik, et al.
Publicado: (2020)

Brain tissue pulsatility is related to clinical features of Parkinson's disease
por: Shirzadi, Zahra, et al.
Publicado: (2018)

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
por: Hall, Sara, et al.
Publicado: (2018)

Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review
por: Zhang, Yu, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
por: Magdalinou, Nadia, et al.
Publicado: (2014)

A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes
por: Li, Qi, et al.
Publicado: (2022)

Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
por: Dutta, Suman, et al.
Publicado: (2023)

Emerging Concepts of Motor Reserve in Parkinson’s Disease
por: Chung, Seok Jong, et al.
Publicado: (2020)

Parkinson’s disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients
por: Perez-Lloret, Santiago, et al.
Publicado: (2009)

Modeling Parkinson’s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells
por: Mishima, Takayasu, et al.
Publicado: (2018)

Corrigendum: Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review
por: Zhang, Yu, et al.
Publicado: (2020)

Imaging tau pathology in Parkinsonisms
por: Coakeley, Sarah, et al.
Publicado: (2017)

Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
por: Lam, Benjamin, et al.
Publicado: (2013)

Clinical dementia severity associated with ventricular size is differentially moderated by cognitive reserve in men and women
por: Sapkota, Shraddha, et al.
Publicado: (2018)

Brain atrophy trajectories predict differential functional performance in Alzheimer's disease: Moderations with apolipoprotein E and sex
por: Sapkota, Shraddha, et al.
Publicado: (2021)

Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes()()
por: Garraux, Gaëtan, et al.
Publicado: (2013)

Elevated Serum SIRT 2 May Differentiate Parkinson’s Disease From Atypical Parkinsonian Syndromes
por: Singh, Amrendra Pratap, et al.
Publicado: (2019)

Parkinsonian Symptoms, Not Dyskinesia, Negatively Affect Active Life Participation of Dyskinetic Patients with Parkinson’s Disease
por: Goubault, Etienne, et al.
Publicado: (2020)

LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson’s Disease and Parkinsonian Syndromes Patients
por: Gątarek, Paulina, et al.
Publicado: (2020)

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
por: Hansson, Oskar, et al.
Publicado: (2017)

MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review
por: Bougea, Anastasia
Publicado: (2022)

The Parkinsonian Personality: More Than Just a “Trait”
por: Luca, Antonina, et al.
Publicado: (2019)

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies
por: Weil, Rimona S., et al.
Publicado: (2017)

Modeling the origin of parkinsonian tremor
por: Dovzhenok, Andrei, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_snq57guqetb9315pb0o4v1aebg